Skip to main content
RAPS Convergence 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Pre-Registration or Sign-up
Requires Pre-Registration or Sign-up
Additional Registration Fee
Additional Registration Fee
Invitation Only
Invitation Only
Student Program
Student Program
Networking Opportunity
Networking Opportunity
RAPS Focus Area
RAPS Focus Area
Back

Mary Jo Salerno, MS PT, MPH

Science Policy Analyst
US Food and Drug Administration

Mary Jo Salerno is a science policy analyst on the Rare Diseases Team in the Office of New Drugs, Center for Drug Evaluation and Research. Mary Jo is the regulatory and administrative lead for the Rare Disease Endpoint Advancement pilot program. Prior to working on the Rare Diseases Team, Mary Jo worked as a senior regulatory project manager in CDER Office of Biostatistics, where she was the CDER regulatory and administrative lead for the Complex Innovative Design program.  Mary Jo also has broad FDA experience as a policy analyst and regulatory project manager in Center for Tobacco Products, Office of the Commissioner Office of the Executive Secretariat, and Europe Office (in the former Office of International Programs).  Prior to her FDA career, Mary Jo worked in the pharmaceutical (vaccine) industry, as a clinician (physical therapist), and as an officer in the United States Navy.  Mary Jo received her Bachelor of Science from the U.S. Naval Academy, her Master of Science in Physical Therapy from Washington University School of Medicine (St Louis, MO), and her Master of Public Health from Johns Hopkins Bloomberg School of Public Health.

Disclosure information not submitted.

Presentation(s):